The accompanying text that “Swiss doctors have reported that cartilage cells harvested from patients’ own noses have been used to successfully produce cartilage transplants for the treatment of the knees of 10 adults with damaged cartilage. Two years after reconstruction, most recipients reported improvements in pain, knee function, and quality of life” refers to the Phase I trial conducted by USB.